422 Final Safety Data From a Randomised Phase III Trial (CIBOMA/2004-01_GEICAM/2003-11) Assessing Adjuvant Capecitabine Maintenance Therapy After Standard Chemotherapy for Triple-negative Early Breast Cancer. a Study From Coalicion Iberoamericana De Investigacion En Oncologia Mamaria (CIBOMA) and Grupo Español De Investigacion En Cancer De Mama (GEICAM)

✍ Scribed by A. Lluch; M. Ruiz-Borrego; C.H. Barrios; J. Bines; L. Torrecillas; J.G. Segalla; A. Ruiz; J.A. Garcia-Saenz; R. Torres; M. Martin

• Book ID: 117662329
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 75 KB
• Volume: 48
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/s0959-8049(12)70488-4